79672-26-7Relevant articles and documents
MODIFIED PROTEINS AND PROTEIN DEGRADERS
-
Paragraph 00582-00584, (2021/12/08)
Provided herein are compounds, pharmaceutical compositions, and methods for binding or degrading target proteins. Further provided herein are compounds having a DNA damage-binding protein 1 (DDB1) binding moiety. Some such embodiments include a linker. Some such embodiments include a target protein binding moiety. Further provided herein are ligand-DDB1 complexes. Further provided herein are in vivo modified DDB1 proteins.
Radicicol derivatives
-
, (2008/06/13)
Radicicol derivatives represented by the following formula (I) having tyrosine kinase inhibition activity or pharmacologically acceptable salts thereof: wherein R1and R2are the same or different, and each represents hydrogen, alkanoy